Corporate Governance

The Board has a good mix of pharmaceutical experience and professional management. Decision-making is decentralized, with accountability and freedom to operate.Under the leadership and supervision of the Board of Directors assisted by a qualified and experienced team of professionals in the fields of production, research and development, marketing, HR, finance, purchase and administration, Consera Pharma has successfully integrated its operations. All projects have been implemented with no cost or time overruns. All major decisions are made globally after consultation with experienced professionals in their specific areas of activity. Decisions and execution are targeted to derive value addition in everything that the company does.

Operations are conducted with utmost financial discipline. The management follows up to ensure that trust in employees is reciprocated with fairness in all dealings. All decisions are taken in the interest of shareholders. The Board and management are aware and conscious of the interests of minority shareholders and do everything to enhance shareholder value in totality. The company is keen to share its gains and has a decent dividend record.

The company has also been issuing bonus shares from time to time. Value creation for shareowners is a cornerstone and is consistently managed. Committees of directors are appointed to focus on specific areas. Consera Pharma is undergoing a process of transformation in a professional environment.The Board of Directors meets as often as business demands, and all meetings are well attended.

Epnew-1-1_045603481_197

Ephraim Eugin Consera

Chief Executive Officer
Eunew-1_045603481_210

Eugin Consera

Managing Director
IMG-20190331-WA0011-removebg-preview-1_045603481_225

Irelin Eugin Consera

President & Chief Operating Officer
Veronica-1_045603481_227

Weronika Baldys

Chief Administrative Officer
WhatsApp-Image-2021-04-26-at-12.21.50-AM-1-removebg-preview-1_045603481_228

Daniel Philip Varghese

Chief Financial Officer
zaiba-new-1_045603481_229

Zaiba Akhtar

Chief Ethics, Risk & Compliance Officer
WhatsApp-Image-2021-04-26-at-3.57.27-AM-removebg-preview-1_045603481_230

Dr. Josephine Ekong, MD

Vice President, Research & Development
Salma-1_045603481_231

Salma Zahour

Vice President, International Trade
user-1_045603481_232

Sara

Vice President, Corporate Development
WhatsApp-Image-2021-04-26-at-11.51.34-PM-removebg-preview-1_045603481_233

Justine Benjamin Kweyamba

Regional Vice President (Africa)
IMG-20210426-WA0003-1-removebg-preview-1_045603481_234

Sherina Friskila Nurtiara

Vice President, Marketing
Bott-1_045603481_235

Botlenyana Ncholo

Vice President, Sales